Alleged violations of the Code during an event
If, as per your judgment, actions were taken during the conduct of a scientific event, with which the participation/sponsorship by a company that has signed the Code of Ethics of the Research-based Pharmaceutical Industry in Bulgaria raises doubts about a potential violation of the provisions of Article 10 of the Code, please report for them.
BJCN 2025 Annual Assembly
BJCN-MORÉ 2025 National Oncology Conference
Last update:
7/15/25
Organized by:
Bulgarian Joint Cancer Network (BJCN)
Place:
International Hotel, Golden Sands
City:
Varna
Start date:
7/15/25
End date:
7/15/25
App. Nr. of HCP:
250
Specialists:
oncology, varia
Website:
Any practice that might create confusion about the real scientific and educational purpose of scientific events sponsored by industry or to which industry sponsors HCPs should not be tolerated.
ARPharM Final Assessment:
02/06/26
Location and Venue
Hospitality Provided (Directly or Indirectly) to HCP
Син - The information available on the event website at the time of the preliminary assessment does not provide sufficient detail to allow for a preliminary assessment.
Other Activities
Син - The information available on the event website at the time of the preliminary assessment does not provide sufficient detail to allow for a preliminary assessment.
Accompanying Persons
The information available on the event website at the time of the preliminary assessment does not provide sufficient detail to allow for a preliminary assessment.
Scientific Programme Schedule / Structure
The programme on the event’s website is preliminary. – The full programme should be available 3 months in advance of the event, at the latest. The programme posted on the event’s website at the time of the assessment does not provide enough detail to allow a valuable pre-assessment. Article 94, Article 10
Legend
ARPharM’s pre-assessment process is ongoing.
Based on information provided through one of the ways described above (on the date indicated), arrangements would not raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
Based on information provided through one of the ways described above (on the date indicated), arrangements may raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
It is always recommended to check the rules prevailing under applicable national codes.
EXHIBITIONS: please read carefully the provisions of the ARPharM HCP Code and the additional guidance.